UniProt ID | MLF1_HUMAN | |
---|---|---|
UniProt AC | P58340 | |
Protein Name | Myeloid leukemia factor 1 | |
Gene Name | MLF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 268 | |
Subcellular Localization | Cytoplasm . Nucleus . Shuttles between the cytoplasm and nucleus. | |
Protein Description | Involved in lineage commitment of primary hemopoietic progenitors by restricting erythroid formation and enhancing myeloid formation. Interferes with erythropoietin-induced erythroid terminal differentiation by preventing cells from exiting the cell cycle through suppression of CDKN1B/p27Kip1 levels. Suppresses COP1 activity via CSN3 which activates p53 and induces cell cycle arrest. Binds DNA and affects the expression of a number of genes so may function as a transcription factor in the nucleus.. | |
Protein Sequence | MFRMLNSSFEDDPFFSESILAHRENMRQMIRSFSEPFGRDLLSISDGRGRAHNRRGHNDGEDSLTHTDVSSFQTMDQMVSNMRNYMQKLERNFGQLSVDPNGHSFCSSSVMTYSKIGDEPPKVFQASTQTRRAPGGIKETRKAMRDSDSGLEKMAIGHHIHDRAHVIKKSKNKKTGDEEVNQEFINMNESDAHAFDEEWQSEVLKYKPGRHNLGNTRMRSVGHENPGSRELKRREKPQQSPAIEHGRRSNVLGDKLHIKGSSVKSNKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MFRMLNSSFEDDPF -CCCCCCCCCCCCCC | 32.23 | 29978859 | |
8 | Phosphorylation | MFRMLNSSFEDDPFF CCCCCCCCCCCCCCC | 31.42 | 25106551 | |
16 | Phosphorylation | FEDDPFFSESILAHR CCCCCCCCHHHHHHH | 30.71 | 23186163 | |
18 | Phosphorylation | DDPFFSESILAHREN CCCCCCHHHHHHHHH | 23.00 | 23186163 | |
23 | Dimethylation | SESILAHRENMRQMI CHHHHHHHHHHHHHH | 31.23 | - | |
23 | Methylation | SESILAHRENMRQMI CHHHHHHHHHHHHHH | 31.23 | 30762609 | |
27 | Dimethylation | LAHRENMRQMIRSFS HHHHHHHHHHHHHCC | 34.20 | - | |
27 | Methylation | LAHRENMRQMIRSFS HHHHHHHHHHHHHCC | 34.20 | 30762615 | |
32 | Phosphorylation | NMRQMIRSFSEPFGR HHHHHHHHCCCCCCC | 23.38 | 30266825 | |
34 | Phosphorylation | RQMIRSFSEPFGRDL HHHHHHCCCCCCCCC | 45.68 | 30266825 | |
43 | Phosphorylation | PFGRDLLSISDGRGR CCCCCCCCCCCCCCC | 27.61 | 23090842 | |
45 | Phosphorylation | GRDLLSISDGRGRAH CCCCCCCCCCCCCCC | 30.54 | 23090842 | |
48 | Methylation | LLSISDGRGRAHNRR CCCCCCCCCCCCCCC | 36.09 | 30988097 | |
48 | Phosphorylation | LLSISDGRGRAHNRR CCCCCCCCCCCCCCC | 36.09 | 27251275 | |
50 | Methylation | SISDGRGRAHNRRGH CCCCCCCCCCCCCCC | 31.17 | 97812407 | |
50 | Phosphorylation | SISDGRGRAHNRRGH CCCCCCCCCCCCCCC | 31.17 | 27251275 | |
63 | Phosphorylation | GHNDGEDSLTHTDVS CCCCCCCCCCCCCHH | 30.75 | 30622161 | |
65 | Phosphorylation | NDGEDSLTHTDVSSF CCCCCCCCCCCHHHH | 27.04 | 30622161 | |
67 | Phosphorylation | GEDSLTHTDVSSFQT CCCCCCCCCHHHHHH | 32.62 | 25693802 | |
70 | Phosphorylation | SLTHTDVSSFQTMDQ CCCCCCHHHHHHHHH | 28.39 | 25693802 | |
71 | Phosphorylation | LTHTDVSSFQTMDQM CCCCCHHHHHHHHHH | 22.63 | 25954137 | |
74 | Phosphorylation | TDVSSFQTMDQMVSN CCHHHHHHHHHHHHH | 22.24 | 25954137 | |
80 | Phosphorylation | QTMDQMVSNMRNYMQ HHHHHHHHHHHHHHH | 21.40 | 25954137 | |
85 | Phosphorylation | MVSNMRNYMQKLERN HHHHHHHHHHHHHHH | 7.20 | 25954137 | |
88 | Ubiquitination | NMRNYMQKLERNFGQ HHHHHHHHHHHHHCC | 35.47 | - | |
97 | Phosphorylation | ERNFGQLSVDPNGHS HHHHCCCCCCCCCCC | 19.31 | 25693802 | |
108 | Phosphorylation | NGHSFCSSSVMTYSK CCCCCCCCCCEEHHH | 28.29 | 28985074 | |
109 | Phosphorylation | GHSFCSSSVMTYSKI CCCCCCCCCEEHHHC | 10.30 | 25693802 | |
112 | Phosphorylation | FCSSSVMTYSKIGDE CCCCCCEEHHHCCCC | 23.61 | 28985074 | |
113 | Phosphorylation | CSSSVMTYSKIGDEP CCCCCEEHHHCCCCC | 7.00 | 28985074 | |
114 | Phosphorylation | SSSVMTYSKIGDEPP CCCCEEHHHCCCCCC | 14.50 | 29496907 | |
122 | Acetylation | KIGDEPPKVFQASTQ HCCCCCCCEEEECCC | 67.41 | 25038526 | |
122 | Ubiquitination | KIGDEPPKVFQASTQ HCCCCCCCEEEECCC | 67.41 | 21906983 | |
147 | Phosphorylation | TRKAMRDSDSGLEKM HHHHHHHCCCHHHHH | 24.26 | 24173317 | |
149 | Phosphorylation | KAMRDSDSGLEKMAI HHHHHCCCHHHHHHH | 49.59 | 30622161 | |
153 | Acetylation | DSDSGLEKMAIGHHI HCCCHHHHHHHCHHH | 38.38 | 25038526 | |
168 | Acetylation | HDRAHVIKKSKNKKT HHHHHHHHHCCCCCC | 50.32 | 24888395 | |
169 | Acetylation | DRAHVIKKSKNKKTG HHHHHHHHCCCCCCC | 56.38 | 24888403 | |
174 | Ubiquitination | IKKSKNKKTGDEEVN HHHCCCCCCCCHHHH | 68.11 | 21906983 | |
205 | Acetylation | EWQSEVLKYKPGRHN HHHHHHHHCCCCCCC | 57.30 | 25038526 | |
206 | Phosphorylation | WQSEVLKYKPGRHNL HHHHHHHCCCCCCCC | 20.46 | 18083107 | |
219 | Methylation | NLGNTRMRSVGHENP CCCCCCCCCCCCCCC | 25.54 | 24395539 | |
220 | Phosphorylation | LGNTRMRSVGHENPG CCCCCCCCCCCCCCC | 24.09 | 25394399 | |
228 | Phosphorylation | VGHENPGSRELKRRE CCCCCCCCHHHHHCC | 24.68 | 30622161 | |
236 | Ubiquitination | RELKRREKPQQSPAI HHHHHCCCCCCCHHH | 46.44 | 21906983 | |
240 | Phosphorylation | RREKPQQSPAIEHGR HCCCCCCCHHHHHCC | 15.85 | 24702127 | |
249 | Phosphorylation | AIEHGRRSNVLGDKL HHHHCCCCCCCCCCC | 29.90 | 30622161 | |
255 | Acetylation | RSNVLGDKLHIKGSS CCCCCCCCCEECCCC | 39.92 | 25038526 | |
261 | Phosphorylation | DKLHIKGSSVKSNKK CCCEECCCCCCCCCC | 27.27 | 30622161 | |
262 | Phosphorylation | KLHIKGSSVKSNKK- CCEECCCCCCCCCC- | 42.08 | 30622161 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MLF1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MLF1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MLF1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...